Premium
Radioimmunoassay of alpha‐fetoprotein: A contribution to the diagnosis of choriocarcinoma and hydatidiform mole
Author(s) -
Seppälä M.,
Bagshawe K. D.,
Ruoslahti E.
Publication year - 1972
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.2910100306
Subject(s) - choriocarcinoma , radioimmunoassay , alpha fetoprotein , mole , chorioepithelioma , fetus , pregnancy , alpha (finance) , medicine , gynecology , obstetrics , biology , surgery , construct validity , hepatocellular carcinoma , patient satisfaction , genetics
Determination of the circulating alpha fetoprotein (AFP) can be used to differentiate between choriocarcinoma or hydatidiform mole and normal pregnancy. Whilst a positive pregnancy test is common to all these states, the serum AFP was found to be elevated only when a fetus was present.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom